Skip to main content
SpringerLink
Log in

WHO signal reports: dronedarone, mometasone

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Savage R.Dronedarone, hyperthyroidism and decreased Thyroid Stimulating Hormone. WHO Pharmaceuticals Newsletter: 14-18, No. 4, 17 Aug 2012

  2. Boyd I.Mometasone and Arrhythmia. WHO Pharmaceuticals Newsletter: 20-24, No. 4, 17 Aug 2012

  3. Sanofi.Response from MAH, Sanofi, regarding a signal between Dronedarone Hyperthyroidism and decreased Thyroid Stimulating Hormone. WHO Pharmaceuticals Newsletter: 19, No. 4, 17 Aug 2012

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

WHO signal reports: dronedarone, mometasone. React. Wkly. 1417, 2 (2012). https://doi.org/10.2165/00128415-201214170-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214170-00002

Keywords

Search

Navigation